160 related articles for article (PubMed ID: 8545606)
1. Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines.
Heinmöller E; Schropp T; Kisker O; Simon B; Seitz R; Weinel RJ
Scand J Gastroenterol; 1995 Oct; 30(10):1008-16. PubMed ID: 8545606
[TBL] [Abstract][Full Text] [Related]
2. Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines.
Heinmöller E; Weinel RJ; Heidtmann HH; Salge U; Seitz R; Schmitz I; Müller KM; Zirngibl H
J Cancer Res Clin Oncol; 1996; 122(12):735-44. PubMed ID: 8954171
[TBL] [Abstract][Full Text] [Related]
3. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits tumor cell-induced platelet aggregation.
Sheu JR; Lin CH; Peng HC; Teng CM; Huang TF
Jpn J Cancer Res; 1993 Oct; 84(10):1062-71. PubMed ID: 8226281
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin.
Swaim MW; Chiang HS; Huang TF
Eur J Cancer; 1996 Apr; 32A(4):715-21. PubMed ID: 8695278
[TBL] [Abstract][Full Text] [Related]
5. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
6. The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells.
Chiang HS; Yang RS; Huang TF
Br J Cancer; 1995 Feb; 71(2):265-70. PubMed ID: 7841039
[TBL] [Abstract][Full Text] [Related]
7. Signaling pathways for induction of platelet aggregation by SAS tongue cancer cells--a mechanism of hematogenous metastasis.
Chang MC; Chan CP; Ho YS; Lee JJ; Lin PS; Lin BR; Huang YL; Hahn LJ; Yeh HW; Wang YJ; Jeng JH
J Oral Pathol Med; 2009 May; 38(5):434-40. PubMed ID: 18811671
[TBL] [Abstract][Full Text] [Related]
8. Plasma-dependent and -independent mechanisms of platelet aggregation induced by human tumour cell lines.
Scarlett JD; Thurlow PJ; Connellan JM; Louis CJ
Thromb Res; 1987 Jun; 46(5):715-26. PubMed ID: 3629545
[TBL] [Abstract][Full Text] [Related]
9. Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin.
Chiang HS; Swaim MW; Huang TF
Breast Cancer Res Treat; 1995 Mar; 33(3):225-35. PubMed ID: 7749150
[TBL] [Abstract][Full Text] [Related]
10. Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin.
Chiang HS; Swaim MW; Huang TF
Br J Haematol; 1994 Jun; 87(2):325-31. PubMed ID: 7947275
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin effects of native and recombinant hirudins.
Markwardt F; Stürzebecher J; Glusa E
Biomed Biochim Acta; 1990; 49(5):399-404. PubMed ID: 2271010
[TBL] [Abstract][Full Text] [Related]
12. The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation.
Macfarlane DE; Walsh PN; Mills DC; Holmsen H; Day HJ
Br J Haematol; 1975 Aug; 30(4):457-63. PubMed ID: 811245
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin.
Lunven C; Gauffeny C; Lecoffre C; O'Brien DP; Roome NO; Berry CN
Thromb Haemost; 1996 Jan; 75(1):154-60. PubMed ID: 8713795
[TBL] [Abstract][Full Text] [Related]
15. Effect of thrombin inhibitors on platelet functions: comparative analysis of DuP 714 and hirudin.
Reilly TM; Knabb RM; Hassell SM; Bozarth JM; Forsythe MS; Mayo MC; Racanelli AL; Mousa SA
Blood Coagul Fibrinolysis; 1992 Oct; 3(5):513-7. PubMed ID: 1450317
[TBL] [Abstract][Full Text] [Related]
16. The activation of platelet aggregation by human cholangiocarcinoma cells is mediated through thrombin receptor.
Akarasereenont P; Chotewuttakorn S; Aiamsa-Ard T; Thaworn A
J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S710-21. PubMed ID: 12002913
[TBL] [Abstract][Full Text] [Related]
17. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
Gandossi E; Lunven C; Gauffeny C; Roome NO; Berry CN
Thromb Haemost; 1998 Nov; 80(5):840-4. PubMed ID: 9843181
[TBL] [Abstract][Full Text] [Related]
18. Aggregation of human platelets in plasma by porcine blood cells in vitro is probably mediated by thrombin generation.
Benatuil L; Fernandez AZ; Romano E
Xenotransplantation; 2003 Sep; 10(5):454-9. PubMed ID: 12950988
[TBL] [Abstract][Full Text] [Related]
19. Protracted treatment with phorbol ester modulates J-7 human hepatoma-cell-induced aggregation and coagulation of human platelet-rich plasma.
Ko FN; Yu SM; Teng CM
Int J Cancer; 1994 Dec; 59(5):706-11. PubMed ID: 7960244
[TBL] [Abstract][Full Text] [Related]
20. Effects of prostacyclin on tumor cell-induced platelet aggregation.
Menter DG; Onoda JM; Taylor JD; Honn KV
Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
